RXO, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing a return to quarterly operating income after nine months of aggregate operating losses.

Key Highlights

  • Q3 2026 revenue of $1,871 million, up from $1,421 million in Q3 2025, according to the filing.
  • Q3 2026 net income of $3 million, compared to a net loss of $14 million in the same quarter of 2025.
  • Nine-month net loss of $42 million, narrowed from a $54 million loss in the nine months ended September 30, 2025.
  • Debt extinguishment loss of $11 million recorded in the nine months ended September 30, 2026, with no comparable charge in the prior-year period.
  • Total assets of $3,496 million as of September 30, 2026, versus $3,277 million at December 31, 2025.
  • 164,951,056 shares outstanding as of October 27, 2026, per the cover page disclosure.
  • Operating cash outflow of $22 million for the nine months ended September 30, 2026, compared to cash provided by operations of $44 million in the year-ago period.

RXO's Third Quarter 2026 Financial Results: Revenue Growth Alongside Ongoing Year-to-Date Losses

According to the filing, RXO, Inc. (NYSE:RXO) reported third-quarter 2026 revenue of $1,871 million, a significant increase from $1,421 million in Q3 2025. Cost of transportation and services rose to $1,538 million from $1,137 million year over year. The company reported Q3 operating income of $17 million, compared to an operating loss of $7 million in Q3 2025. After accounting for interest expense, net of $10 million and an income tax provision of $3 million, net income for the quarter was $3 million, or $0.02 per basic and diluted share.

For the nine months ended September 30, 2026, the filing disclosed revenue of $5,070 million against $4,273 million in the comparable prior-year period. The nine-month operating loss was $10 million, an improvement from a $37 million operating loss in the same period of 2025. A debt extinguishment loss of $11 million and interest expense, net, of $28 million contributed to a nine-month pre-tax loss of $51 million. The income tax benefit of $9 million reduced the net loss to $42 million, or $0.25 per basic and diluted share.

On the balance sheet, the filing reported total assets of $3,496 million at September 30, 2026, compared to $3,277 million at December 31, 2025. Goodwill remained unchanged at $1,111 million. Long-term debt and obligations under finance leases increased to $461 million from $387 million at year-end 2025. The company reported an accumulated deficit of $426 million as of September 30, 2026, up from $384 million at December 31, 2025. Cash flow from operating activities was a use of $22 million for the nine-month period, driven in part by a $261 million increase in accounts receivable, per the filing.

What Was Disclosed

RXO, Inc. disclosed its unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2026, covering income, cash flows, and balance sheet positions, along with notes and management discussion as required under Form 10-Q.